A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
Guo, Menglin, Shu, Yamin, Chen, Guosong, Li, Juan, Li, Feie
Published in Scientific reports (29.11.2022)
Published in Scientific reports (29.11.2022)
Get full text
Journal Article
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
Yang, Yang, Shu, Yamin, Chen, Guosong, Yin, Yanchao, Li, Feie, Li, Juan
Published in PloS one (07.12.2022)
Published in PloS one (07.12.2022)
Get full text
Journal Article
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Yin, Yanchao, Shu, Yamin, Zhu, Junru, Li, Feie, Li, Juan
Published in Scientific reports (15.11.2022)
Published in Scientific reports (15.11.2022)
Get full text
Journal Article
Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Zhang, Qilin, Wu, Pan, He, Xucheng, Ding, Yufeng, Shu, Yamin
Published in Frontiers in oncology (01.12.2021)
Published in Frontiers in oncology (01.12.2021)
Get full text
Journal Article
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li, Juan Li
Published in PloS one (07.12.2022)
Published in PloS one (07.12.2022)
Get full text
Journal Article
Cost-effectiveness of sintilimab plus chemotherapy versus chemotherapy alone as first-line treatment of locally advanced or metastatic oesophageal squamous cell carcinoma
Liu, Lulu, Wang, Lei, Chen, Li, Ding, Yiling, Zhang, Qilin, Shu, Yamin
Published in Frontiers in immunology (23.01.2023)
Published in Frontiers in immunology (23.01.2023)
Get full text
Journal Article
Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis
Zhang, Wenting, Xu, Ziqi, Shu, Yamin, Shu, Sainan, Zhang, Qilin
Published in Pharmaceuticals (Basel, Switzerland) (05.08.2024)
Published in Pharmaceuticals (Basel, Switzerland) (05.08.2024)
Get full text
Journal Article
Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china
Shu, Yamin, Liu, Yanxin, He, Xucheng, Ding, Yufeng, Zhang, Qilin
Published in Frontiers in pharmacology (12.08.2022)
Published in Frontiers in pharmacology (12.08.2022)
Get full text
Journal Article
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for EGFR-mutated advanced non-small-cell lung cancer in China
Shu, Yamin, Ding, Yufeng, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin
Published in Frontiers in pharmacology (20.09.2022)
Published in Frontiers in pharmacology (20.09.2022)
Get full text
Journal Article
Induction of apoptosis in S180 tumour bearing mice by polysaccharide from Lentinus edodes via mitochondria apoptotic pathway
Zhang, Yu, Li, Qiang, Shu, Yamin, Wang, Hongjing, Zheng, Ziming, Wang, Jinglin, Wang, Kaiping
Published in Journal of functional foods (01.05.2015)
Published in Journal of functional foods (01.05.2015)
Get full text
Journal Article